ClinConnect ClinConnect Logo
Search / Trial NCT06962033

PRIDE III Prison Interventions and HIV Prevention Collaboration

Launched by YALE UNIVERSITY · Apr 29, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The PRIDE III trial is exploring how to improve access to a treatment called Opioid Agonist Therapy (OAT) for people who use opioids and are involved with the justice system, such as prisons and probation in four countries: Tajikistan, Kyrgyzstan, Moldova, and Georgia. The researchers want to understand what obstacles exist that make it difficult to offer this treatment and how to create a supportive learning environment for those providing OAT. They will also analyze the effectiveness of these efforts in helping individuals who inject drugs.

To participate in this study, individuals must be at least 18 years old and currently involved in probation, either as a provider or as someone receiving support. They will gather information through surveys and focus groups, which will help them identify specific needs and challenges. This study is not yet recruiting participants, but it aims to make a significant impact on improving health care for people dealing with opioid use and HIV in these communities.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aim 1:
  • 1. Quantitative surveys for prison OAT providers
  • Being 18 years or older
  • Being currently assigned and working as a probation OAT provider for a probation site
  • 2. ECHO procedures
  • Aim 2:
  • 1. Quantitative surveys for people in probation
  • Being 18 years or older
  • Screen yes to opioid injection on the online screener questionnaire
  • Currently in probation
  • 2. Quantitative surveys for probation and prison officers
  • Being 18 years or older
  • Being currently assigned and working as a probation or prison officer at a probation site
  • 3. Focus Groups (People in probation)
  • Being 18 years or older
  • Screen yes to opioid injection criteria on the online screener
  • Currently in probation
  • 4. Focus Groups (Probation and prison officers)
  • Being 18 years or older
  • Being currently assigned and working as a probation or prison officer at a probation
  • Has more than 3 months of field experience
  • Works at a probation site within 25 kilometers of an OAT site
  • Exclusion Criteria:
  • -

About Yale University

Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.

Locations

New Haven, Connecticut, United States

Tbilisi, , Georgia

Bishkek, , Kyrgyzstan

Chisinau, , Moldova, Republic Of

Dushanbe, , Tajikistan

Patients applied

0 patients applied

Trial Officials

Frederick L Altice, MD

Principal Investigator

Yale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported